Nanomedicine for the reduction of the thrombogenicity of stent coatings

The treatment of patients with drug-eluting stents (DES) continues to evolve with the current emergence of DES technology that offers a combination of pharmacological and mechanical approaches to prevent arterial restenosis. However, despite the promising short-term and mid-term outcomes of DES, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Karagkiozaki, Varvara C, Logothetidis, Stergios D, Kassavetis, Spyridon N, Giannoglou, George D
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865019/
https://www.ncbi.nlm.nih.gov/pubmed/20463940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865019/
https://www.ncbi.nlm.nih.gov/pubmed/20463940

Ejemplares similares